Search
Returning search results with filters:
Remove filter for
Category: Health products
Remove filter for
Issue: Product safety
Remove filter for
Type: Alert
Clear all
Search filters
Type
Audience
Category
Issue
Last updated
Displaying 166 - 180 of 193 items.
TECENTRIQ® (atezolizumab) - Risk of Immune-Related Myositis
AlertHealth professional risk communication | 2019-03-13
Multiple Losartan-containing drugs voluntarily recalled because of potential for nitrosamine impurity
AlertInformation update | 2019-03-09
Health Canada recommends that children and youth not use cough and cold products that contain opioids
AlertInformation update | 2019-02-18
Health Canada will be updating its safety review of breast implants
AlertInformation update | 2019-02-12
Important new safety information regarding the use of hydrochlorothiazide and the risk of non-melanoma skin cancer
AlertInformation update | 2019-01-31
LARTRUVO (olaratumab) - New clinical trial information important to prescribing decisions
AlertHealth professional risk communication | 2019-01-30
XARELTO (rivaroxaban) - Increase in all-cause mortality, thromboembolic and bleeding events in patients after transcatheter aortic valve replacement
AlertHealth professional risk communication | 2018-12-20
Information Update - Mylan-Valsartan medications voluntarily recalled as a precaution due to an impurity
AlertInformation update | 2018-11-28
XOFIGO® (radium Ra 223 dichloride) - Increased Incidence of Fractures and Trend for Increased Deaths with XOFIGO used in combination with abiraterone and prednisone/prednisolone
AlertHealth professional risk communication | 2018-11-08
Health Canada reminds Canadians of the risks of decorative contact lenses
AlertInformation update | 2018-10-12
Health Canada reminds Canadians to consult a health professional before using high-concentration hydroquinone products
AlertInformation update | 2018-09-25
TECENTRIQ® (atezolizumab) - Risk of Immune-Related Nephritis
AlertHealth professional risk communication | 2018-09-18
EpiPen (epinephrine USP) Auto-Injector - Interim Order allowing the importation of AUVI-Q in response to shortages of EpiPen and EpiPen Jr
AlertHealth professional risk communication | 2018-08-29
Drug and Alcohol Use During Orientation Week
AlertInformation update | 2018-08-20
Expansion of recall of valsartan drugs to include additional lots, as a precaution
AlertInformation update | 2018-08-18